ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Human Insulin Inhalation Powder in Patients With Type 2 Diabetes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00325364
Recruitment Status : Completed
First Posted : May 12, 2006
Last Update Posted : March 9, 2018
Sponsor:
Collaborator:
Alkermes, Inc.
Information provided by (Responsible Party):
Eli Lilly and Company

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 2008
  Actual Study Completion Date : May 2008
  Certification/Extension First Submitted : March 7, 2018